168 related articles for article (PubMed ID: 28789820)
21. Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.
Artenie AA; Zang G; Daniel M; Fortier E; Jutras-Aswad D; Puzhko S; Bruneau J
Int J Drug Policy; 2017 Sep; 47():239-243. PubMed ID: 28587944
[TBL] [Abstract][Full Text] [Related]
22. Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco.
Mirzazadeh A; Chen YH; Lin J; Burk K; Wilson EC; Miller D; Veloso D; McFarland W; Morris MD
PLoS One; 2021; 16(4):e0249585. PubMed ID: 33798243
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system.
Gibbs D; Price O; Grebely J; Larney S; Sutherland R; Read P; Butler K; Degenhardt L; Peacock A
Drug Alcohol Depend; 2021 Nov; 228():109050. PubMed ID: 34607193
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands.
Helsper CW; Janssen MP; van Essen GA; Croes EA; van der Veen C; de Wit AG; de Wit NJ
Int J Drug Policy; 2017 Sep; 47():117-125. PubMed ID: 28826994
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort Study.
Boucher LM; Bayoumi AM; Mark AE; Cooper C; Martin A; Marshall Z; Boyd R; Oickle P; Diliso N; Pineau D; Renaud B; LeBlanc S; Tyndall M; Lee OM; Kendall CE
Subst Use Misuse; 2019; 54(1):18-30. PubMed ID: 29932800
[TBL] [Abstract][Full Text] [Related]
26. Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia.
Gibbs D; Grebely J; Sutherland R; Larney S; Butler K; Dietze PM; Starr M; Peacock A
Drug Alcohol Rev; 2021 Nov; 40(7):1349-1353. PubMed ID: 33759276
[TBL] [Abstract][Full Text] [Related]
27. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.
Jones L; Atkinson A; Bates G; McCoy E; Porcellato L; Beynon C; McVeigh J; Bellis MA
Int J Drug Policy; 2014 Mar; 25(2):204-11. PubMed ID: 24332457
[TBL] [Abstract][Full Text] [Related]
28. Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high-prevalence settings.
Scott N; Sacks-Davis R; Pedrana A; Doyle J; Thompson A; Hellard M
J Viral Hepat; 2018 Dec; 25(12):1472-1480. PubMed ID: 30047625
[TBL] [Abstract][Full Text] [Related]
29. A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J;
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891535
[TBL] [Abstract][Full Text] [Related]
30. Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs.
Latham NH; Pedrana A; Doyle JS; Howell J; Williams B; Higgs P; Thompson AJ; Hellard ME
J Viral Hepat; 2019 Jul; 26(7):919-922. PubMed ID: 30801881
[TBL] [Abstract][Full Text] [Related]
31. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
[TBL] [Abstract][Full Text] [Related]
32. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
[TBL] [Abstract][Full Text] [Related]
33. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
Graham S; Maher L; Wand H; Doyle M; Iversen J
Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
[TBL] [Abstract][Full Text] [Related]
34. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
[TBL] [Abstract][Full Text] [Related]
35. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
[TBL] [Abstract][Full Text] [Related]
36. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
Spelman T; Morris MD; Zang G; Rice T; Page K; Maher L; Lloyd A; Grebely J; Dore GJ; Kim AY; Shoukry NH; Hellard M; Bruneau J;
J Epidemiol Community Health; 2015 Aug; 69(8):745-52. PubMed ID: 25814695
[TBL] [Abstract][Full Text] [Related]
37. Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia.
Butsashvili M; Abzianidze T; Kamkamidze G; Gulbiani L; Gvinjilia L; Kuchuloria T; Tskhomelidze I; Gogia M; Tsereteli M; Miollany V; Kikvidze T; Shadaker S; Nasrullah M; Averhoff F
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):23. PubMed ID: 35346265
[TBL] [Abstract][Full Text] [Related]
38. 'Beyond the willing & the waiting' - The role of peer-based approaches in hepatitis C diagnosis & treatment.
Henderson C; Madden A; Kelsall J
Int J Drug Policy; 2017 Dec; 50():111-115. PubMed ID: 28927831
[TBL] [Abstract][Full Text] [Related]
39. The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia.
Gunn J; O'Keefe D; Draper BL; Djordjevic F; Ryan K; Kerr P; Elsum I; Gold J; Layton C; Chan K; Dietze P; Higgs P; Doyle J; Stoové MA; Hellard M; Pedrana A
BMJ Open; 2023 Jul; 13(7):e071665. PubMed ID: 37400235
[TBL] [Abstract][Full Text] [Related]
40. Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
Anwar I; Donadille C; Protopopescu C; Michels D; Herin J; Pladys A; Bader D; Carrieri P; Roux P
Harm Reduct J; 2023 Jul; 20(1):98. PubMed ID: 37516889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
